These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11572142)

  • 1. Bioregulators as instruments of terror.
    Kagan E
    Clin Lab Med; 2001 Sep; 21(3):607-18, ix-x. PubMed ID: 11572142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioregulators as prototypic nontraditional threat agents.
    Kagan E
    Clin Lab Med; 2006 Jun; 26(2):421-43, ix. PubMed ID: 16815460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The toxicology of bioregulators as potential agents of bioterrorism.
    Bokan S
    Arh Hig Rada Toksikol; 2005 Jun; 56(2):205-11. PubMed ID: 15968837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognizing the real threat of biological terror.
    Wenzel RP
    Trans Am Clin Climatol Assoc; 2002; 113():42-53; discussion 53-5. PubMed ID: 12053717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biological and toxin terrorism weapons].
    Bokan S
    Arh Hig Rada Toksikol; 2003 Mar; 54(1):29-43. PubMed ID: 14574772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical management of biological warfare and bioterrorism: place of the immunoprevention and the immunotherapy.
    Binder P; Attre O; Boutin JP; Cavallo JD; Debord T; Jouan A; Vidal D
    Comp Immunol Microbiol Infect Dis; 2003 Oct; 26(5-6):401-21. PubMed ID: 12818625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Tetracyclines and ciprofloxacin as treatment for children and pregnant or lactating women in the era of biological terror].
    Aizenstien O; Lehavi O; Sagi R
    Harefuah; 2002 May; 141 Spec No():100-4, 119, 118. PubMed ID: 12170543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Origin and evolution of peptide-protein bioregulators].
    Chipens GI; Freĭdlin IS; Skliarova SN
    Zh Evol Biokhim Fiziol; 1987; 23(3):361-72. PubMed ID: 3303757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccines against biologic agents: uses and developments.
    Ales NC; Katial RK
    Respir Care Clin N Am; 2004 Mar; 10(1):123-46. PubMed ID: 15062232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upflow anaerobic sludge blanket reactor--a review.
    Bal AS; Dhagat NN
    Indian J Environ Health; 2001 Apr; 43(2):1-82. PubMed ID: 12397675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical aspects of toxin weapons.
    Bigalke H; Rummel A
    Toxicology; 2005 Oct; 214(3):210-20. PubMed ID: 16087285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The next agent of terror? Understanding smallpox & its implications for prehospital crews.
    Brocato CE; Miller GT
    JEMS; 2002 Mar; 27(3):44-50, 52-5. PubMed ID: 11913182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biological agents turning into weapons].
    Rotman E; Cohen A; Hourvitz A
    Harefuah; 2002 May; 141 Spec No():16-20, 124, 123. PubMed ID: 12170547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparedness for a bioterrorism event in Alaska. Part 1: Detection and identification of a biologic event.
    Funk EA
    Alaska Med; 2000; 42(4):101-13. PubMed ID: 14593880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bioterrorism, parasites as potential bioterrorism agents and biosecurity studies].
    Aksoy U
    Mikrobiyol Bul; 2006; 40(1-2):129-39. PubMed ID: 16775968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fungi and fungal toxins as weapons.
    Paterson RR
    Mycol Res; 2006 Sep; 110(Pt 9):1003-10. PubMed ID: 16908123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infectious agents of bioterrorism: a review for emergency physicians.
    Kman NE; Nelson RN
    Emerg Med Clin North Am; 2008 May; 26(2):517-47, x-xi. PubMed ID: 18406986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viral vectors for use in the development of biodefense vaccines.
    Lee JS; Hadjipanayis AG; Parker MD
    Adv Drug Deliv Rev; 2005 Jun; 57(9):1293-314. PubMed ID: 15935875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retroviruses and other latent viruses: the deadliest of pathogens are not necessarily the best candidates for bioterrorism.
    Salgado CD; Kilby JM
    J S C Med Assoc; 2009 Jun; 105(3):104-6. PubMed ID: 19639767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current therapy and the development of therapeutic options for the treatment of diseases due to bacterial agents of potential biowarfare and bioterrorism.
    Greenfield RA; Bronze MS
    Curr Opin Investig Drugs; 2004 Feb; 5(2):135-40. PubMed ID: 15043386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.